Baird Financial Group’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $29.3M | Buy |
466,080
+144,877
| +45% | +$10.1M | 0.05% | 271 |
|
|
2025
Q4 | $21.3M | Sell |
321,203
-181,133
| -36% | -$11.7M | 0.03% | 357 |
|
|
2025
Q3 | $33.8M | Sell |
502,336
-135,429
| -21% | -$10.7M | 0.05% | 253 |
|
|
2025
Q2 | $55.7M | Sell |
637,765
-49,243
| -7% | -$3.86M | 0.1% | 174 |
|
|
2025
Q1 | $46.9M | Buy |
687,008
+285,105
| +71% | +$23.3M | 0.09% | 189 |
|
|
2024
Q4 | $31.3M | Sell |
401,903
-62,357
| -13% | -$4.62M | 0.06% | 262 |
|
|
2024
Q3 | $31.1M | Sell |
464,260
-450,293
| -49% | -$37M | 0.06% | 266 |
|
|
2024
Q2 | $104M | Sell |
914,553
-62,208
| -6% | -$7.86M | 0.22% | 96 |
|
|
2024
Q1 | $135M | Sell |
976,761
-13,372
| -1% | -$1.68M | 0.28% | 73 |
|
|
2023
Q4 | $123M | Buy |
990,133
+78,239
| +9% | +$7.99M | 0.28% | 74 |
|
|
2023
Q3 | $85.1M | Buy |
911,894
+109,397
| +14% | +$12.3M | 0.23% | 97 |
|
|
2023
Q2 | $103M | Buy |
802,497
+133,299
| +20% | +$16.1M | 0.27% | 80 |
|
|
2023
Q1 | $77.7M | Buy |
669,198
+4,330
| +0.7% | +$485K | 0.19% | 118 |
|
|
2022
Q4 | $75.3M | Sell |
664,868
-16,972
| -2% | -$1.86M | 0.2% | 114 |
|
|
2022
Q3 | $54.9M | Buy |
681,840
+39,027
| +6% | +$3.31M | 0.16% | 150 |
|
|
2022
Q2 | $47.9M | Buy |
642,813
+9,137
| +1% | +$834K | 0.13% | 180 |
|
|
2022
Q1 | $81M | Buy |
633,676
+15,836
| +3% | +$1.73M | 0.2% | 111 |
|
|
2021
Q4 | $82.9M | Sell |
617,840
-219,756
| -26% | -$31.6M | 0.19% | 126 |
|
|
2021
Q3 | $115M | Sell |
837,596
-9,580
| -1% | -$1.21M | 0.29% | 75 |
|
|
2021
Q2 | $90.4M | Buy |
847,176
+266,952
| +46% | +$25.6M | 0.24% | 100 |
|
|
2021
Q1 | $52.1M | Sell |
580,224
-37,784
| -6% | -$3.55M | 0.15% | 172 |
|
|
2020
Q4 | $57.1M | Sell |
618,008
-27,468
| -4% | -$2.45M | 0.17% | 159 |
|
|
2020
Q3 | $66.5M | Sell |
645,476
-21,116
| -3% | -$2.21M | 0.23% | 116 |
|
|
2020
Q2 | $67.6M | Sell |
666,592
-395,744
| -37% | -$35.4M | 0.25% | 98 |
|
|
2020
Q1 | $71.5M | Buy |
1,062,336
+195,780
| +23% | +$12.2M | 0.33% | 61 |
|
|
2019
Q4 | $47.4M | Buy |
+866,556
| New | +$41.1M | 0.17% | 144 |
|
|
2016
Q3 | – | Sell |
-88,924
| Closed | -$1.76M | – | 1200 |
|
|
2016
Q2 | $1.76M | Sell |
88,924
-568
| -0.6% | -$9.67K | 0.02% | 584 |
|
|
2016
Q1 | $1.52M | Sell |
89,492
-33,832
| -27% | -$565K | 0.01% | 602 |
|
|
2015
Q4 | $2.52M | Sell |
123,324
-15,600
| -11% | -$325K | 0.03% | 481 |
|
|
2015
Q3 | $2.98M | Buy |
138,924
+15,524
| +13% | +$346K | 0.03% | 434 |
|
|
2015
Q2 | $2.47M | Buy |
+123,400
| New | +$2.17M | 0.02% | 502 |
|
Other funds holding DXCM
VCM
VPM
Baird Financial Group's DXCM Position: Q1 2026 in Review
Baird Financial Group increased its DexCom (DXCM) stake by 45% in Q1 2026, buying an estimated $10.1M and bringing the position to 466,080 shares worth $29.3M. The position accounts for 0.05% of the portfolio, ranked #271.
Baird Financial Group first reported a position in DXCM in Q2 2015 and has held it in 31 quarters since. The position peaked at $135M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Baird Financial Group held 466,080 shares of DexCom worth $29.3M as of Q1 2026.
- Baird Financial Group bought 144,877 DexCom shares in Q1 2026, an estimated $10.1M.
- DexCom made up 0.05% of Baird Financial Group's portfolio in Q1 2026, its #271 holding.
- Baird Financial Group first reported a position in DexCom in Q2 2015 and has held it in 31 quarters since.
- Baird Financial Group's DexCom position peaked at $135M in Q1 2024.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.